• Skip to main content

DistilGovHealth

DistilNFO GovHealth Advisory

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Controversial ‘three-person’ baby born in Greece

Share:

April 17, 2019

In “medical history” which could help infertile couples around the world, Spanish and Greek fertility doctors have genetically engineered a baby from three people bar a woman’s infertility. The baby boy was born a healthy 2.9kg (6lbs). The 32-year-old Greek woman had endured four unsuccessful cycles of IVF previously, but her son now has a tiny amount of his genetic makeup from a donor woman.

The Greek team worked with Spanish Embryotools Centre on the trial, which has also reported that eight other embryos are ready to be implanted. Dr. Panagiotis Psathas, president of the Institute of Life in Athens, was proud to announce the international innovation in assisted reproduction, “It is now possible for women with multiple IVF failures or rare mitochondrial genetic diseases to have a healthy child.”

The experimental form of IVF was developed to overcome deadly mitochondrial diseases passed down from mother to baby – using genetic information from the father and mother and another donor egg. Although mitochondria have their own DNA, combining the mother’s DNA with a donor’s mitochondria could prevent defective mitochondria in mitochondrial diseases.

While there is untested speculation that mitochondria may have a role in a successful pregnancy, some English experts say the recent procedure should not have taken place as it raises ethical questions.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

In February 2018, doctors in Newcastle who pioneered the technology were given permission on two attempts to create the UK’s first three-person babies, both in families with rare mitochondrial diseases, but other doctors argued that the two applications – fertility and disease prevention – are morally different.

Tim Child, of Oxford University and Medical Director of The Fertility Partnership, has noted no proven need for the patient to have her genetic material removed and transferred into the eggs of a donor, which may otherwise be acceptable if being used to treat mitochondrial disease – the patient may have still conceived with further standard IVF treatment.”

Regardless, some fertility doctors believe the safe technology could increase the odds of IVF in future.

Date: April 17, 2019

Source: Healthcare Asia Daily

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Major Payers Find HHS Finalized Nondiscrimination Rule Too NarrowMajor Payers Find HHS Finalized Nondiscrimination Rule Too Narrow
  • New Clinically Validated Sleepcheck App LaunchesNew Clinically Validated Sleepcheck App Launches
  • Apple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care SectorApple Still has a Lot of Room to Grow in the $3.5 Trillion Health Care Sector
  • Google Moves Further Into Healthcare: a Timeline of the Last YearGoogle Moves Further Into Healthcare: a Timeline of the Last Year
  • Superb Healthcare At Ultra-Low Prices? How Singapore Does ItSuperb Healthcare At Ultra-Low Prices? How Singapore Does It
  • AI, Machine Learning, and Blockchain are Key for Healthcare InnovationAI, Machine Learning, and Blockchain are Key for Healthcare Innovation

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications